refractory acute leukemia

Showing 1 - 7 of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

CNS Tumor, Infantile Fibrosarcoma, Recurrent Acute Leukemia Trial in Canada, United States (Larotrectinib Sulfate)

Active, not recruiting
  • Central Nervous System Neoplasm
  • +4 more
  • Larotrectinib Sulfate
  • Birmingham, Alabama
  • +81 more
Jan 24, 2023

Recurrent Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Blastic Plasmacytoid Dendritic Cell Tumor Trial in

Recruiting
  • Recurrent Acute Leukemia
  • +16 more
  • Duarte, California
    City of Hope Medical Center
Nov 22, 2022

Acute Myeloid Leukemia, Refractory Acute Leukemia, Relapsed Adult AML Trial in Suzhou (CAHAG regimen, Placebo regimen)

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • CAHAG regimen
  • Placebo regimen
  • Suzhou, Jiangsu, China
    The First Affliated Hospital of Soochow University
Oct 10, 2021

Acute Myeloid Leukemia With FLT3/ITD Mutation, Recurrent Acute Myeloid Leukemia, Refractory Acute Leukemia Trial in Houston

Recruiting
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
May 13, 2020

Relapsed Acute Leukemia, Refractory Acute Leukemia Trial in Philadelphia (Bortezomib with mitoxantrone, etoposide and

Completed
  • Relapsed Acute Leukemia
  • Refractory Acute Leukemia
  • Bortezomib with mitoxantrone, etoposide and cytarabine
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Apr 23, 2018

Refractory Acute Leukemia Trial in Jerusalem (Allogeneic hematopoietic stem-cell-transplantation)

Unknown status
  • Refractory Acute Leukemia
  • Allogeneic hematopoietic stem-cell-transplantation
  • Jerusalem, Israel
    Hadassah Medical Organization
Feb 18, 2016

Relapsed Acute Leukemia, Refractory Acute Leukemia, High-Risk Myelodysplasia Trial in Baltimore, New York (PD 0332991)

Terminated
  • Relapsed Acute Leukemia
  • +2 more
  • PD 0332991
  • Baltimore, Maryland
  • +1 more
Aug 30, 2013